Clinical Trials in Pennsylvania

Showing 14001-14020 of 16,895 trials

Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

NCT01678963

The purpose of this study is to evaluate the safety and efficacy of topical ophthalmic squalamine lactate eye drops in treating patients with neovascular age-related macular degeneration (wet AMD), a degenerative retinal eye disease that causes a progressive, irreversible, severe loss of central vision.

Neovascular Age Related Macular Degeneration

Ohr Pharmaceutical Inc.142 participantsStarted Nov 2012

Tucson, Arizona, United States • Bakersfield, California, United States • Beverly Hilss, California, United States +17 more locations

TERMINATEDPhase 336 miles

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

NCT01459913

The purpose of this study is to evaluate if a 12-week total regimen of telaprevir in combination with pegylated interferon alfa 2a (Peg-IFN-alfa-2a) and ribavirin (RBV) (T12/PR12) is safe and effective in subjects who have the interleukin-28B (IL28B) CC genotype. The subjects enrolled in this study will have chronic hepatitis C virus (HCV) infection and will not have cirrhosis of the liver.

Hepatitis C, Chronic

Vertex Pharmaceuticals Incorporated239 participantsStarted Nov 2011

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +80 more locations

Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

Find Trials by Condition in Pennsylvania

Phase 3 Study of EBI-005 in Dry Eye Disease

Red Cell Storage Duration Study

Safety Trial of Naproxen Sodium/ Diphenhydramine

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

CCI-779 in Treating Patients With Metastatic Melanoma

Growth Observational Study

Development of Standards for the New Ballard Maturation Score

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

ALLPS VERSUS PVO Randomized Controlled Trial

Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder